Sankesh Abbhi serves as Executive at BRAINSTORM CELL THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Sankesh Abbhi has executed 3 insider transactions totaling $607.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 10, 2021 involved receiving (via award) 6,666 shares valued at $0.
Sankesh Abbhi currently holds 11,323 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sankesh Abbhi has been a net buyer of BCLI stock. They have purchased $607.7K and sold $0 worth of shares.
Sankesh Abbhi's most recent insider trade was on Dec 10, 2021, when they sold 6,666 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $12.99 |
| Discretionary |
| Apr 6, 2020 | BCLI | $0 | Award | 4,657 | $N/A | Discretionary |